.png)
End Stage Renal Disease Market by Treatment - Global Industry Analysis & Forecast to 2027
Published On : August 2020 Pages : 150 Category: Pharma & Healthcare Report Code : HC0812547
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
End Stage Renal Disease Market by Treatment (Transplantation, Dialysis) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The End Stage Renal Disease Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. End Stage Renal Disease leads to gradual loss of kidney function reaches an advanced state. It occurs when kidneys lose their filtering capabilities, dangerous levels of fluid, electrolytes and wastes can build up in your body.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Nipro Corporation
- Fresenius Medical Care AG & Co. KGaA
- Baxter International, Inc.
- Medtronic Plc
- B. Braun Melsungen AG
- Asahi Kasei Medical Co., Ltd.
- Cantel Medical
- Nikkiso Co., Ltd;
- JMS Co. Ltd
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· End Stage Renal Disease Market, By Treatment, Estimates and Forecast, 2017-2027 ($Million)
o Transplantation
o Dialysis
· End Stage Renal Disease Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Nipro Corporation
o Fresenius Medical Care AG & Co. KGaA
o Baxter International, Inc.
o Medtronic Plc
o B. Braun Melsungen AG
o Asahi Kasei Medical Co., Ltd.
o Cantel Medical
o Nikkiso Co., Ltd;
o JMS Co. Ltd
· End Stage Renal Disease Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America End Stage Renal Disease Market , By Country
o U.S. End Stage Renal Disease Market
o Canada End Stage Renal Disease Market
o Mexico End Stage Renal Disease Market
o Europe
§ Europe End Stage Renal Disease Market , By Country
o Germany End Stage Renal Disease Market
o UK End Stage Renal Disease Market
o France End Stage Renal Disease Market
o Russia End Stage Renal Disease Market
o Italy End Stage Renal Disease Market
o Rest of Europe End Stage Renal Disease Market
o Asia-Pacific
§ Asia-Pacific End Stage Renal Disease Market , By Country
o China End Stage Renal Disease Market
o Japan End Stage Renal Disease Market
o South Korea End Stage Renal Disease Market
o India End Stage Renal Disease Market
o Southeast Asia End Stage Renal Disease Market
o Rest of Asia-Pacific End Stage Renal Disease Market
o South America
§ South America End Stage Renal Disease Market , By Country
o Brazil End Stage Renal Disease Market
o Argentina End Stage Renal Disease Market
o Columbia End Stage Renal Disease Market
o Rest of South America End Stage Renal Disease Market
o Middle East and Africa
§ Middle East and Africa End Stage Renal Disease Market , By Country
o Saudi Arabia End Stage Renal Disease Market
o UAE End Stage Renal Disease Market
o Egypt End Stage Renal Disease Market
o Nigeria End Stage Renal Disease Market
o South Africa End Stage Renal Disease Market
o Rest of MEA End Stage Renal Disease Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. End Stage Renal Disease Market, By Treatment
5.1. Introduction
5.2. Global End Stage Renal Disease Revenue and Market Share by Treatment (2017-2021)
5.2.1. Global End Stage Renal Disease Revenue and Revenue Share by Treatment (2017-2021)
5.3. Transplantation
5.3.1. Global Transplantation Revenue and Growth Rate (2017-2021)
5.4. Dialysis
5.4.1. Global Dialysis Revenue and Growth Rate (2017-2021)
6. End Stage Renal Disease Market, By Region
6.1. Introduction
6.2. Global End Stage Renal Disease Revenue and Market Share by Regions
6.2.1. Global End Stage Renal Disease Revenue by Regions (2017-2021)
6.3. North America End Stage Renal Disease by Countries
6.3.1. North America End Stage Renal Disease Revenue and Growth Rate (2017-2021)
6.3.2. North America End Stage Renal Disease Revenue (Million USD) by Countries (2017-2021)
6.3.3. United States
6.3.3.1. United States End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.4. Canada
6.3.4.1. Canada End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.5. Mexico
6.3.5.1. Mexico End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.4. Europe End Stage Renal Disease by Countries
6.4.1. Europe End Stage Renal Disease Revenue and Growth Rate (2017-2021)
6.4.2. Europe End Stage Renal Disease Revenue (Million USD) by Countries (2017-2021)
6.4.3. Germany
6.4.3.1. Germany End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.4. France
6.4.4.1. France End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.5. UK
6.4.5.1. UK End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.6. Russia
6.4.6.1. Russia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.7. Italy
6.4.7.1. Italy End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.5. Asia-Pacific End Stage Renal Disease by Countries
6.5.1. Asia-Pacific End Stage Renal Disease Revenue and Growth Rate (2017-2021)
6.5.2. Asia-Pacific End Stage Renal Disease Revenue (Million USD) by Countries (2017-2021)
6.5.3. China
6.5.3.1. China End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.4. Japan
6.5.4.1. Japan End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.5. Korea
6.5.5.1. Korea End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.6. India
6.5.6.1. India End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.6. South America End Stage Renal Disease by Countries
6.6.1. South America End Stage Renal Disease Revenue and Growth Rate (2017-2021)
6.6.2. South America End Stage Renal Disease Revenue (Million USD) by Countries (2017-2021)
6.6.3. Brazil
6.6.3.1. Brazil End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.4. Argentina
6.6.4.1. Argentina End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.5. Columbia
6.6.5.1. Columbia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.6. Rest of South America
6.6.6.1. Rest of South America End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.7. Middle East and Africa End Stage Renal Disease by Countries
6.7.1. Middle East and Africa End Stage Renal Disease Revenue and Growth Rate (2017-2021)
6.7.2. Middle East and Africa End Stage Renal Disease Revenue (Million USD) by Countries (2017-2021)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.5. Egypt
6.7.5.1. Egypt End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.6. Nigeria
6.7.6.1. Nigeria End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.7. South Africa
6.7.7.1. South Africa End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.8. Turkey
6.7.8.1. Turkey End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7. Company Profiles
7.1. Nipro Corporation
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. Fresenius Medical Care AG & Co. KGaA
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Baxter International, Inc.
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Medtronic Plc
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. B. Braun Melsungen AG
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Asahi Kasei Medical Co., Ltd.
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. Cantel Medical
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. Nikkiso Co., Ltd;
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
7.9. JMS Co. Ltd
7.9.1. Business Overview
7.9.2. Service Portfolio
7.9.3. Strategic Developments
7.9.4. Financial Overview
8. End Stage Renal Disease Market Forecast (2022-2027)
8.1. Global End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2022-2027)
8.2. End Stage Renal Disease Market Forecast by Regions (2022-2027)
8.2.1. North America End Stage Renal Disease Market Forecast (2022-2027)
8.2.1.1. United States End Stage Renal Disease Market Forecast (2022-2027)
8.2.1.2. Canada End Stage Renal Disease Market Forecast (2022-2027)
8.2.1.3. Mexico End Stage Renal Disease Market Forecast (2022-2027)
8.2.2. Europe End Stage Renal Disease Market Forecast (2022-2027)
8.2.2.1. Germany End Stage Renal Disease Market Forecast (2022-2027)
8.2.2.2. France End Stage Renal Disease Market Forecast (2022-2027)
8.2.2.3. UK End Stage Renal Disease Market Forecast (2022-2027)
8.2.2.4. Russia End Stage Renal Disease Market Forecast (2022-2027)
8.2.2.5. Italy End Stage Renal Disease Market Forecast (2022-2027)
8.2.2.6. Rest of Europe End Stage Renal Disease Market Forecast (2022-2027)
8.2.3. Asia-Pacific End Stage Renal Disease Market Forecast (2022-2027)
8.2.3.1. China End Stage Renal Disease Market Forecast (2022-2027)
8.2.3.2. Japan End Stage Renal Disease Market Forecast (2022-2027)
8.2.3.3. Korea End Stage Renal Disease Market Forecast (2022-2027)
8.2.3.4. India End Stage Renal Disease Market Forecast (2022-2027)
8.2.3.5. Southeast Asia End Stage Renal Disease Market Forecast (2022-2027)
8.2.3.6. Rest of Asia-Pacific End Stage Renal Disease Market Forecast (2022-2027)
8.2.4. South America End Stage Renal Disease Market Forecast (2022-2027)
8.2.4.1. Brazil End Stage Renal Disease Market Forecast (2022-2027)
8.2.4.2. Argentina End Stage Renal Disease Market Forecast (2022-2027)
8.2.4.3. Columbia End Stage Renal Disease Market Forecast (2022-2027)
8.2.4.4. Rest of South America End Stage Renal Disease Market Forecast (2022-2027)
8.2.5. Middle East and Africa End Stage Renal Disease Market Forecast (2022-2027)
8.2.5.1. Saudi Arabia End Stage Renal Disease Market Forecast (2022-2027)
8.2.5.2. United Arab Emirates End Stage Renal Disease Market Forecast (2022-2027)
8.2.5.3. Egypt End Stage Renal Disease Market Forecast (2022-2027)
8.2.5.4. Nigeria End Stage Renal Disease Market Forecast (2022-2027)
8.2.5.5. South Africa End Stage Renal Disease Market Forecast (2022-2027)
8.2.5.6. Turkey End Stage Renal Disease Market Forecast (2022-2027)
8.2.5.7. Rest of Middle East and Africa End Stage Renal Disease Market Forecast (2022-2027)
8.3. End Stage Renal Disease Market Forecast by Treatment (2022-2027)
8.3.1. End Stage Renal Disease Forecast by Treatment (2022-2027)
8.3.2. End Stage Renal Disease Market Share Forecast by Treatment (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure France End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure China End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure India End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa End Stage Renal Disease Revenue (Million USD) and Growth Rate (2017-2027)
Table Global End Stage Renal Disease Revenue and Revenue Share by Treatment (2017-2019)
Figure Global Transplantation Revenue and Growth Rate (2017-2019)
Figure Global Dialysis Revenue and Growth Rate (2017-2019)
Table Global End Stage Renal Disease Revenue by Regions (2017-2019)
Figure North America End Stage Renal Disease Growth Rate (2017-2019)
Figure North America End Stage Renal Disease Revenue and Growth Rate (2017-2019)
Figure North America End Stage Renal Disease by Countries (2017-2019)
Figure North America End Stage Renal Disease Revenue (Million USD) by Countries (2017-2019)
Figure United States End Stage Renal Disease Growth Rate (2017-2019)
Figure United States End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada End Stage Renal Disease Growth Rate (2017-2019)
Figure Canada End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico End Stage Renal Disease Growth Rate (2017-2019)
Figure Mexico End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe End Stage Renal Disease Growth Rate (2017-2019)
Figure Europe End Stage Renal Disease Revenue and Growth Rate (2017-2019)
Figure Europe End Stage Renal Disease by Countries (2017-2019)
Figure Europe End Stage Renal Disease Revenue (Million USD) by Countries (2017-2019)
Figure Germany End Stage Renal Disease Growth Rate (2017-2019)
Figure Germany End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France End Stage Renal Disease Growth Rate (2017-2019)
Figure France End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK End Stage Renal Disease Growth Rate (2017-2019)
Figure UK End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia End Stage Renal Disease Growth Rate (2017-2019)
Figure Russia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy End Stage Renal Disease Growth Rate (2017-2019)
Figure Italy End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe End Stage Renal Disease Growth Rate (2017-2019)
Figure Rest of Europe End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific End Stage Renal Disease Growth Rate (2017-2019)
Figure Asia-Pacific End Stage Renal Disease Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific End Stage Renal Disease by Countries (2017-2019)
Figure Asia-Pacific End Stage Renal Disease Revenue (Million USD) by Countries (2017-2019)
Figure China End Stage Renal Disease Growth Rate (2017-2019)
Figure China End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan End Stage Renal Disease Growth Rate (2017-2019)
Figure Japan End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea End Stage Renal Disease Growth Rate (2017-2019)
Figure Korea End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India End Stage Renal Disease Growth Rate (2017-2019)
Figure India End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia End Stage Renal Disease Growth Rate (2017-2019)
Figure Southeast Asia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific End Stage Renal Disease Growth Rate (2017-2019)
Figure Rest of Asia-Pacific End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America End Stage Renal Disease Growth Rate (2017-2019)
Figure South America End Stage Renal Disease Revenue and Growth Rate (2017-2019)
Figure South America End Stage Renal Disease by Countries (2017-2019)
Figure South America End Stage Renal Disease Revenue (Million USD) by Countries (2017-2019)
Figure Brazil End Stage Renal Disease Growth Rate (2017-2019)
Figure Brazil End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina End Stage Renal Disease Growth Rate (2017-2019)
Figure Argentina End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia End Stage Renal Disease Growth Rate (2017-2019)
Figure Columbia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America End Stage Renal Disease Growth Rate (2017-2019)
Figure Rest of South America End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa End Stage Renal Disease Growth Rate (2017-2019)
Figure Middle East and Africa End Stage Renal Disease Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa End Stage Renal Disease by Countries (2017-2019)
Figure Middle East and Africa End Stage Renal Disease Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia End Stage Renal Disease Growth Rate (2017-2019)
Figure Saudi Arabia End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates End Stage Renal Disease Growth Rate (2017-2019)
Figure United Arab Emirates End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt End Stage Renal Disease Growth Rate (2017-2019)
Figure Egypt End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria End Stage Renal Disease Growth Rate (2017-2019)
Figure Nigeria End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa End Stage Renal Disease Growth Rate (2017-2019)
Figure South Africa End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey End Stage Renal Disease Growth Rate (2017-2019)
Figure Turkey End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa End Stage Renal Disease Growth Rate (2017-2019)
Figure Rest of Middle East and Africa End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Table Nipro Corporation End Stage Renal Disease Financial Overview
Table Fresenius Medical Care AG & Co. KGaA End Stage Renal Disease Financial Overview
Table Baxter International, Inc. End Stage Renal Disease Financial Overview
Table Medtronic Plc End Stage Renal Disease Financial Overview
Table B. Braun Melsungen AG End Stage Renal Disease Financial Overview
Table Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Financial Overview
Table Cantel Medical End Stage Renal Disease Financial Overview
Table Nikkiso Co., Ltd; End Stage Renal Disease Financial Overview
Table JMS Co. Ltd End Stage Renal Disease Financial Overview
Figure Global End Stage Renal Disease Revenue (Millions USD) and Growth Rate (2019-2027)
Table End Stage Renal Disease Market Forecast by Regions (2019-2027)
Figure North America End Stage Renal Disease Market Forecast (2019-2027)
Figure United States End Stage Renal Disease Market Forecast (2019-2027)
Figure Canada End Stage Renal Disease Market Forecast (2019-2027)
Figure Mexico End Stage Renal Disease Market Forecast (2019-2027)
Figure Europe End Stage Renal Disease Market Forecast (2019-2027)
Figure Germany End Stage Renal Disease Market Forecast (2019-2027)
Figure France End Stage Renal Disease Market Forecast (2019-2027)
Figure UK End Stage Renal Disease Market Forecast (2019-2027)
Figure Russia End Stage Renal Disease Market Forecast (2019-2027)
Figure Italy End Stage Renal Disease Market Forecast (2019-2027)
Figure Rest of Europe End Stage Renal Disease Market Forecast (2019-2027)
Figure Asia-Pacific End Stage Renal Disease Market Forecast (2019-2027)
Figure China End Stage Renal Disease Market Forecast (2019-2027)
Figure Japan End Stage Renal Disease Market Forecast (2019-2027)
Figure Korea End Stage Renal Disease Market Forecast (2019-2027)
Figure India End Stage Renal Disease Market Forecast (2019-2027)
Figure Southeast Asia End Stage Renal Disease Market Forecast (2019-2027)
Figure Rest of Asia-Pacific End Stage Renal Disease Market Forecast (2019-2027)
Figure South America End Stage Renal Disease Market Forecast (2019-2027)
Figure Brazil End Stage Renal Disease Market Forecast (2019-2027)
Figure Argentina End Stage Renal Disease Market Forecast (2019-2027)
Figure Columbia End Stage Renal Disease Market Forecast (2019-2027)
Figure Rest of South America End Stage Renal Disease Market Forecast (2019-2027)
Figure Middle East and Africa End Stage Renal Disease Market Forecast (2019-2027)
Figure Saudi Arabia End Stage Renal Disease Market Forecast (2019-2027)
Figure United Arab Emirates End Stage Renal Disease Market Forecast (2019-2027)
Figure Egypt End Stage Renal Disease Market Forecast (2019-2027)
Figure Nigeria End Stage Renal Disease Market Forecast (2019-2027)
Figure South Africa End Stage Renal Disease Market Forecast (2019-2027)
Figure Turkey End Stage Renal Disease Market Forecast (2019-2027)
Figure Rest of Middle East and Africa End Stage Renal Disease Market Forecast (2019-2027)
Figure Global End Stage Renal Disease Forecast by Treatment (2019-2027)
Figure Global End Stage Renal Disease Market Share Forecast by Treatment (2019-2027)
Figure Global End Stage Renal Disease Forecast by Treatment (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|